Skip to content
← Back to this collection

PUBLICATIONS · 16628187

A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2006 Jul
First author
Slovak ML

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Slovak ML
      type
      Author
    2. name
      Gundacker H
      type
      Author
    3. name
      Bloomfield CD
      type
      Author
    4. name
      Dewald G
      type
      Author
    5. name
      Appelbaum FR
      type
      Author
    6. name
      Larson RA
      type
      Author
    7. name
      Tallman MS
      type
      Author
    8. name
      Bennett JM
      type
      Author
    9. name
      Stirewalt DL
      type
      Author
    10. name
      Meshinchi S
      type
      Author
    11. name
      Willman CL
      type
      Author
    12. name
      Ravindranath Y
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Slovak ML
      type
      Author
    2. name
      Gundacker H
      type
      Author
    3. name
      Bloomfield CD
      type
      Author
    4. name
      Dewald G
      type
      Author
    5. name
      Appelbaum FR
      type
      Author
    6. name
      Larson RA
      type
      Author
    7. name
      Tallman MS
      type
      Author
    8. name
      Bennett JM
      type
      Author
    9. name
      Stirewalt DL
      type
      Author
    10. name
      Meshinchi S
      type
      Author
    11. name
      Willman CL
      type
      Author
    12. name
      Ravindranath Y
      type
      Author
    bibliography ids
    1. nci-bib-028b86b8972cb511abfb0ec7
    book metadata
    content sha256
    927cd4dc3f2b49442955f59545f4b90f66d4218be912c7125e23abc979fe7947
    document type
    citation
    dois
    1. 10.1038/sj.leu.2404233
    electronic publication date
    display
    2006 Apr 20
    precision
    day
    year
    2006
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16628187
    immutable id
    pubmed:16628187@927cd4dc3f2b49442955f59545f4b90f66d4218be912c7125e23abc979fe7947
    journal
    abbreviation
    Leukemia
    issn electronic
    Source null
    issn print
    0887-6924
    issue
    7
    name
    Leukemia
    nlm unique id
    8704895
    pages
    1295-7
    volume
    20
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16628187
      provenance
      batch id
      19fb2de9a00882c94e86
      provider
      NCBI PubMed ESummary
      record sha256
      77daebc1043df94698020fcb3d4efdca8c3fff8de3c6a3ee4d12daf68c787dce
      response sha256
      4c446464d8fd06bff771a2bb5f3529ef4abe372e3c19f6fb7223068d839a263d
      retrieved at
      2026-09-09T23:46:06.810486+00:00
      publication date
      display
      2006 Jul
      precision
      month
      year
      2006
      publication types
      1. Letter
      2. Research Support, N.I.H., Extramural
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16628187/
      title
      A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.

      Preserved source evidence · Independent clinical review pending · Not medical advice